No industry has been impacted more by the global pandemic than life sciences, across the board including diagnostics, medical equipment, pharmaceutical, biotech and more. We've seen an acceleration in development, regulatory approvals that have resulted in the availability of many new, amazing therapies. In addition, the way in which companies are operating and working with each other, collaborating across industries, there are incredible lessons learned that we hope to continue.
QAD's Director of Life Sciences, Jennifer Petrosky, and President of Axendia Inc., Daniel Matlis, tell us some of the things you're seeing today and how digital technologies are being adopted across the board to support manufacturing, supply chain and enterprise collaboration.